Title: An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice.
Journal: Nature medicine 20130301
Title: Neuron-specific non-classical release of prothymosin alpha: a novel neuroprotective damage-associated molecular patterns.
Journal: Journal of neurochemistry 20121001
Title: Amlexanox is as effective as dexamethasone in topical treatment of erosive oral lichen planus: a short-term pilot study.
Journal: Oral surgery, oral medicine, oral pathology and oral radiology 20120501
Title: Development of a measure to assess effective listening and interactive communication skills in the delivery of children's rehabilitation services.
Journal: Disability and rehabilitation 20120101
Title: New Evidence-Based Treatment Approach in Behçet's Disease.
Journal: Pathology research international 20120101
Title: Clinical inquiry. What is the most effective way to treat recurrent canker sores?
Journal: The Journal of family practice 20111001
Title: Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents.
Journal: Expert opinion on emerging drugs 20110301
Title: Nicolaus Copernicus: not only a great astronomer but also a physician.
Journal: Journal of nephrology 20110101
Title: Variable initial swing side and prolonged double limb support represent abnormalities of the first three steps of gait initiation in patients with Parkinson's disease with freezing of gait.
Journal: Frontiers in neurology 20110101
Title: Molecular level interactions of S100A13 with amlexanox: inhibitor for formation of the multiprotein complex in the nonclassical pathway of acidic fibroblast growth factor.
Journal: Biochemistry 20100323
Title: Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1.
Journal: Biochemical pharmacology 20090615
Title: RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.
Journal: Journal of translational medicine 20090101
Title: A clinical evaluation of amlexanox oral adhesive pellicles in the treatment of recurrent aphthous stomatitis and comparison with amlexanox oral tablets: a randomized, placebo controlled, blinded, multicenter clinical trial.
Journal: Trials 20090101
Title: PDE4 inhibitors: current status.
Journal: British journal of pharmacology 20081001
Title: [Local Treatment of stomatitis aphthosa].
Journal: Medizinische Monatsschrift fur Pharmazeuten 20080901
Title: Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops.
Journal: Clinical ophthalmology (Auckland, N.Z.) 20080901
Title: Synergistic Ca2+ and Cu2+ requirements of the FGF1-S100A13 interaction measured by quartz crystal microbalance: an initial step in amlexanox-reversible non-classical release of FGF1.
Journal: Neurochemistry international 20080501
Title: Review of over-the-counter treatments for aphthous ulceration and results from use of a dissolving oral patch containing glycyrrhiza complex herbal extract.
Journal: The journal of contemporary dental practice 20080301
Title: Effectiveness of two oral pastes for the treatment of recurrent aphthous stomatitis.
Journal: Oral diseases 20070901
Title: Mucocutaneous lesions of Behcet's disease.
Journal: Yonsei medical journal 20070831
Title: An evaluation on the efficacy and safety of amlexanox oral adhesive tablets in the treatment of recurrent minor aphthous ulceration in a Chinese cohort: a randomized, double-blind, vehicle-controlled, unparallel multicenter clinical trial.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20061001
Title: Evidence for serum-deprivation-induced co-release of FGF-1 and S100A13 from astrocytes.
Journal: Neurochemistry international 20060801
Title: A late cutaneous response in actively sensitized rats: a new method for evaluating the efficacy of antiallergic drugs.
Journal: Journal of pharmacological sciences 20060801
Title: Voltage-dependent N-type Ca2+ channel activity regulates the interaction between FGF-1 and S100A13 for stress-induced non-vesicular release.
Journal: Cellular and molecular neurobiology 20060501
Title: The efficacy of amlexanox OraDisc on the prevention of recurrent minor aphthous ulceration.
Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 20060201
Title: Olopatadine suppresses the migration of THP-1 monocytes induced by S100A12 protein.
Journal: Mediators of inflammation 20060101
Title: Molecular mechanism of inhibition of nonclassical FGF-1 export.
Journal: Biochemistry 20051129
Title: A comparative study of the efficacy of Aphtheal in the management of recurrent minor aphthous ulceration.
Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 20050801
Title: Prediction of genotoxicity of chemical compounds by statistical learning methods.
Journal: Chemical research in toxicology 20050601
Title: Amlexanox for the treatment of recurrent aphthous ulcers.
Journal: Clinical drug investigation 20050101
Title: Hsp90 is a direct target of the anti-allergic drugs disodium cromoglycate and amlexanox.
Journal: The Biochemical journal 20030901
Title: Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 protein.
Journal: Biochemical and biophysical research communications 20020412
Title: Selecting topical and systemic agents for recurrent aphthous stomatitis.
Journal: Cutis 20010901
Title: The precursor but not the mature form of IL1alpha blocks the release of FGF1 in response to heat shock.
Journal: The Journal of biological chemistry 20010216
Title: Treatment strategies for recurrent oral aphthous ulcers.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010101
Title: The comparative release of FGF1 by hypoxia and temperature stress.
Journal: Growth factors (Chur, Switzerland) 20010101
Title: Mechanism of action of an antiallergic agent, amlexanox (AA-673), in inhibiting histamine release from mast cells. Acceleration of cAMP generation and inhibition of phosphodiesterase.
Journal: International archives of allergy and applied immunology 19870101
Title: Reilly SM, et al. An inhibitor of the protein kinases TBK1 and IKK-e improves obesity-related metabolic dysfunctions in mice. Nat Med. 2013 Mar;19(3):313-21.
Title: Bell, J. AmLexanox for the treatment of recurrent aphthous ulcers. Clin Drug Investig, 2005. 25(9): p. 555-66.
Title: Zhang Y, et al. AmLexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss. Sci Rep. 2015 Sep 4;5:13575.
